肺移植中ECMO支持:美国住院费用当代分析
基于美国全国住院患者样本2000-2011年数据,分析15,596例肺移植受者中658例(4.2%)需ECMO支持者的住院费用。ECMO组中位费用为780,391.50美元,显著高于非ECMO组的324,279.80美元,且住院时间更长;双侧肺移植、肺动脉高压、黑种人及Medicare参保者费用更高。
要点
- 肺移植需ECMO者中位住院费用为780,391.50美元,较非ECMO者高50.3%。
- ECMO组中位住院时间25天,显著长于非ECMO组的15天。
- 双侧肺移植、肺动脉高压、黑种人及Medicare参保者住院费用更高。
核心结论
- 肺移植需ECMO支持者住院时间更长、费用更高,黑种人、肺动脉高压患者及Medicare参保者费用尤其增高。
研究设计与样本
- 利用美国全国住院患者样本(Nationwide Inpatient Sample)回顾性分析2000至2011年15,596例肺移植受者数据,按是否使用ECMO分组,采用回归模型分析费用差异。
主要发现
- 658例(4.2%)受者需要ECMO,ECMO组更常见特发性肺纤维化(3.5% vs 1.3%,p=0.007)和肺动脉高压(9.1% vs 3.0%,p<0.001)。
- ECMO组中位住院费用为780,391.50美元,非ECMO组为324,279.80美元,ECMO组费用高50.3%(95%CI:33.0%至67.5%,p<0.001)。
- 双侧肺移植费用高32.1%(95%CI:26.2%至37.9%,p<0.001),肺动脉高压患者费用高28.7%(95%CI:14.9%至42.4%,p=0.001)。
- Medicare参保者费用较私人保险者高6.6%(95%CI:0.7%至12.5%,p=0.028),黑种人受者费用高约34.2%(95%CI:3.2%至65.0%,p=0.030)。
- ECMO组中位住院时间25天,非ECMO组15天(p<0.001)。
临床怎么用
- 肺移植围术期需ECMO支持者应预期更长住院时间和更高费用,资源规划需考虑肺动脉高压、双侧移植、黑种人及Medicare参保等高费用因素。
局限性
- 原文未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is little in the literature pertaining to cost associated with the use of extracorporeal membrane oxygenation (ECMO) in lung transplantation. We sought to evaluate charges associated with the index hospitalization among recipients of a lung transplant who required ECMO to identify factors that increase hospital charges in these patients. METHODS: With the use of the Nationwide Inpatient Sample, we reviewed data pertaining to patients who received a lung transplant between 2000 and 2011 and stratified them into ECMO and non-ECMO groups based on use of ECMO. Regression modeling was used to identify differences in charges. RESULTS: Data pertaining to 15,596 recipients of a lung transplant were evaluated, 658 (4.2%) of whom required ECMO. ECMO recipients were more likely to have a diagnosis of idiopathic pulmonary fibrosis (3.5% versus 1.3%, p = 0.007) or pulmonary hypertension (PH) (9.1% versus 3.0%, p < 0.001). Patients who received a bilateral lung transplant had 32.1% (95% confidence interval [CI]: 26.2% to 37.9%, p < 0.001) higher charges. Recipients with PH had 28.7% (95% CI: 14.9% to 42.4%, p = 0.001) higher charges. Median charges for recipients of a lung transplant who required ECMO were $780,391.50 versus $324,279.80 for non-ECMO recipients of a lung transplant and were 50.3% (95% CI: 33.0% to 67.5%, p < 0.001) higher. Hospital charges among Medicare enrollees were 6.6% (95% CI: 0.7% to 12.5%, p = 0.028) higher than privately insured recipients of a lung transplant. Black recipients had approximately 34.2% (95% CI: 3.2% to 65.0%, p = 0.030) higher charges. The ECMO group had longer median length of stay (LOS) (25 versus 15 days, p < 0.001). CONCLUSIONS: Recipients of a lung transplant who required ECMO support had longer LOS and higher hospital charges, specifically among black recipients, recipients with PH, and Medicare enrollees.
引用
- Hayanga JWA, Shigemura N, Aboagye JK, et al. ECMO Support in Lung Transplantation: A Contemporary Analysis of Hospital Charges in the United States. Ann Thorac Surg. 2017. PMID: 28688632. doi:10.1016/j.athoracsur.2017.04.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。